There has been tremendous progress in Artificial Intelligence (AI) for music, in particular for musical composition and access to large databases for commercialisation through the Internet. We are interested in further advancing this field, focusing on composition. In contrast to current black-box AI methods, we are championing an interpretable compositional outlook on generative music systems. In particular, we are importing methods from the Distributional Compositional Categorical (DisCoCat) modelling framework for Natural Language Processing (NLP), motivated by musical grammars. Quantum computing is a nascent technology, which is very likely to impact the music industry in time to come. Thus, we are pioneering a Quantum Natural Language Processing (QNLP) approach to develop a new generation of intelligent musical systems. This work follows from previous experimental implementations of DisCoCat linguistic models on quantum hardware. In this chapter, we present Quanthoven, the first proof-of-concept ever built, which (a) demonstrates that it is possible to program a quantum computer to learn to classify music that conveys different meanings and (b) illustrates how such a capability might be leveraged to develop a system to compose meaningful pieces of music. After a discussion about our current understanding of music as a communication medium and its relationship to natural language, the chapter focuses on the techniques developed to (a) encode musical compositions as quantum circuits, and (b) design a quantum classifier. The chapter ends with demonstrations of compositions created with the system.

Quick and accurate medical diagnosis is crucial for the successful treatment of a disease. Using machine learning algorithms, we have built two models to predict a hematologic disease, based on laboratory blood test results. In one predictive model, we used all available blood test parameters and in the other a reduced set, which is usually measured upon patient admittance. Both models produced good results, with a prediction accuracy of 0.88 and 0.86, when considering the list of five most probable diseases, and 0.59 and 0.57, when considering only the most probable disease. Models did not differ significantly from each other, which indicates that a reduced set of parameters contains a relevant fingerprint of a disease, expanding the utility of the model for general practitioner's use and indicating that there is more information in the blood test results than physicians recognize. In the clinical test we showed that the accuracy of our predictive models was on a par with the ability of hematology specialists. Our study is the first to show that a machine learning predictive model based on blood tests alone, can be successfully applied to predict hematologic diseases and could open up unprecedented possibilities in medical diagnosis.